摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-bis[dicyanoargentato(I)]tetrakis(imidazole)cadmium(II) | 175029-37-5

中文名称
——
中文别名
——
英文名称
trans-bis[dicyanoargentato(I)]tetrakis(imidazole)cadmium(II)
英文别名
——
trans-bis[dicyanoargentato(I)]tetrakis(imidazole)cadmium(II)化学式
CAS
175029-37-5
化学式
C16H16Ag2CdN12
mdl
——
分子量
704.53
InChiKey
FMKHKXDPUMRKCI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为产物:
    描述:
    咪唑 、 aqueous cadmium chloride 、 potassium dicyanoargentate(I) 在 citric acid 、 2-aminoethanol 作用下, 以 为溶剂, 生成 trans-bis[dicyanoargentato(I)]tetrakis(imidazole)cadmium(II)
    参考文献:
    名称:
    A Dicyanoargentate(I) Rod Behaving as a Discrete Anion, a Monodentate Shaft or Shank, and an Ambidentate Shaft in the Crystal Structures of Imidazole-Blade Ligated Cadmium(II) Dicyanoargentate(I) Complexes:  trans-Bis[dicyanoargentato(I)]tetrakis(imidazole)cadmium(II), [Dicyanoargentato(I)]pentakis(imidazole)cadmium(II) Dicyanoargentate(I), catena-Poly[tetrakis(N-methylimidazole)cadmium(II)-trans-μ-dicyanoargentato(I)] Dicyanoargentate(I), and catena-Poly[tetrakis(2-methylimidazole)cadmium(II)-trans-μ-dicyanoargentato(I)] Dicyanoargentate(I) Hydrate
    摘要:
    The crystal structures of four [dicyanoargentato(I)]cadmium(II) complexes with the mixed ligation of imidazole (imH: C3H4N2) or N-methyl- or 2-methylimidazole (N-Meim or 2-MeimH: C3H6N2) On the cadmium(II), [Cd(imH)(4){Ag(CN)(2)}(2)] (1a), [Cd(imH)(5){Ag(CN)(2)}][Ag(CN)(2)] (1b), [Cd(N-Meim)(4){Ag(CN)(2)}][Ag(CN)(2)] (2), and [Cd(2-MeimH)(4){Ag(CN)(2)}][Ag(CN)(2)]. H2O (3), have been determined by single-crystal X-ray diffraction methods. Complex la crystallizes in the orthorhombic Pbmn space group with a = 22.206(2) Angstrom, b = 10.306(1) Angstrom, c = 10.318(1) Angstrom, Z = 4. 1b: monoclinic P2(1)/n, a = 9.028(4) Angstrom, b = 13.988(6) Angstrom, c = 22.079(4) Angstrom, beta = 101.02(2)degrees, Z = 4. 2: monoclinic C2/m, a = 11.1292(8) Angstrom, b = 11.435(3) Angstrom, c = 11.266(1) Angstrom, beta = 94.252(8)degrees, Z = 2. 3: orthorhombic Pnnm, a = 11.212(2) Angstrom, b = 11.156(5) Angstrom, c = 23.646(5) Angstrom, Z = 4. Complex la has the shape of a four-blade propeller consisting of [Cd(imH)(4)](2+) with the shaft being the monodentate [-NCAgCN](-) anions. 1b comprises the discrete [Ag(CN)(2)](-) and the umbrella-shaped [Cd(imH)(5)NCAgCN](+) in which the monodentate [Ag(CN)(2)](-) behaves as the shank; hydrogen-bond networks among the umbrellas build up a three-dimensional lattice. In 2 and 3 the four-blade propellers of [Cd(N-Meim)(4)](2+) and [Cd(2-MeimH)(4)](2+) are successively linked at every Cd by the ambidentate -NCAgCN- rods to form an infinite chain, respectively; the discrete [Ag(CN)(2)](-) anions and the H2O in 3 are accommodated in the interchain space. The varieties in coordination behavior of [Ag(CN)(2)](-) can be interpreted in terms of the hydrogen-bond formation between a pyrrole H of the imidazole ligand and an unbridged N-end of [Ag(CN)(2)](-).
    DOI:
    10.1021/ic950629g
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)